Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026, May 2026 and Sep 2026.
- Largest single sale: $5.7M (35,378 shares) of Axsome Therapeutics, Inc. on Feb 26, 2026. Filing
- Last sale before this period: Sep 22, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Axsome Therapeutics, Inc. (AXSM) | Chief Operating Officer | Mar 9, 2020 | Sep 3, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 3, 2026, Axsome Therapeutics, Inc.: sold 10,000 shares for $2.1M, under a disclosed plan; 10,000 shares acquired by exercising options. 1 filing: 1
- May 5, 2026, Axsome Therapeutics, Inc.: sold 233 shares for $53K, under a disclosed plan; 233 shares acquired by exercising options. 1 filing: 1
- May 4, 2026, Axsome Therapeutics, Inc.: sold 4,517 shares for $1.0M, under a disclosed plan; 4,517 shares acquired by exercising options. 1 filing: 1
- Feb 26, 2026, Axsome Therapeutics, Inc.: sold 35,378 shares for $5.7M, under a disclosed plan; 35,378 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.